Merck KGaA has dosed the first patient in its Phase III clinical programme, evaluating enpatoran in individuals with lupus who...
LEO Pharma has signed a definitive agreement for the acquisition of Replay, which focuses on treating rare genetic dermatological conditions.The...
Ray Therapeutics has received PRIME designation from the EMA for its RTx-015 gene therapy to treat retinitis pigmentosa (RP).The post...
enVVeno Medical has received the IDE approval from the US FDA for a pivotal study involving a non-surgical replacement venous...
Precision BioSciences has begun patient enrolment for its Phase I/II FUNCTION-DMD clinical trial of PBGENE-DMD for DMD.The post Precision begins...
Abbott has received the US FDA approval and CE Mark for its Ultreon 3.0 artificial intelligence (AI)-powered coronary imaging platform.The...
Massive Bio and OpenAI are to expand access to clinical studies via AI-driven protocol parameterisation and real-time patient pre-screening.The post...
Rocket Pharmaceuticals has signed an agreement to sell its rare paediatric disease PRV for $180m to advance its gene therapy...
Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system.The post Nervonik closes...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.